Grow with An Eye on the Exit: Are SPACs Right for You? – Q Bay Talks with Silicon Valley Bank

2021 has been a record year for biotech initial public offerings, with total deal value already up by 50% compared with all of 2020. However, most recently there has been an unexpected surge in Special Purpose Acquisition Companies (SPACs) mergers and acquisitions (M&As) as a way of entering the public market during the Covid-19 pandemic compared with traditional IPOs. As a very trending direction, what is the advantages and disadvantages brought by going public via a SPAC? Are SPACs Right for You?

On January 26, 2022, from 1:00 pm – 2:00 pm Q Bay Training Series is hosting an event, entitled, “Grow with An Eye on the Exit: Are SPACs Right for You?,” with Li Song, Managing Director of Asia Link Team at Silicon Valley Bank.

Listeners will learn about
1.How do SPACs work?
2.The unique advantages/disadvantages to tech firms?
3.How do SPACs stack up against traditional IPO and M&As in terms of creating shareholder value?
4.The current state of the SPACs market?
5.Where do the SPACs sector go from here?
6.Top three things you must do to get your firms SPAC ready?

Li Song is a managing director of SVB Financial Group’s Asia Link practice, which promotes cross-border financial and banking services for innovation sectors in both the US and Asia. Since joining SVB in 2000, Li has had the pleasure of collaborating with over 1,000 innovative startups, some of which grew to hundred billion market cap companies while some others never made it. Li has been taking detail notes of the secret sauce that fueled successful tech startups’ growth and the common mistakes those failed ones made. As an Asia expert residing in the US, Li also advises US clients on the best banking practices of entering the Asia market and vice versa.